CIK 0001689375
- Accelerated filer
- Smaller reporting company
- Emerging growth company
Entrada Therapeutics, Inc.
Sign in to watch- Ticker
- TRDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813983399
- Phone
- +1 857-305-1825
- Business address
- ONE DESIGN CENTER PLACE, SUITE 17-500, BOSTON, MA, 02210
- Former names
- CycloPorters, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,200,939
- in 8 filings
Net −$7,200,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 21 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-18 | WENTWORTH KORY JAMES Chief Financial Officer | Option exercise | +100 | $2.10 | $210 | 20,441 |
| 2022-08-18 | WENTWORTH KORY JAMES Chief Financial Officer | Sale | −200 | $13.00 | $3K | 20,221 |
| 2022-08-18 | WENTWORTH KORY JAMES Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −100 | 115,896 | ||
| 2022-08-17 | WENTWORTH KORY JAMES Chief Financial Officer | Option exercise | +100 | $2.10 | $210 | 20,541 |
| 2022-08-17 | WENTWORTH KORY JAMES Chief Financial Officer | Sale | −200 | $13.07 | $3K | 20,341 |
| 2022-08-17 | WENTWORTH KORY JAMES Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −100 | 115,996 | ||
| 2022-08-16 | WENTWORTH KORY JAMES Chief Financial Officer | Option exercise | +100 | $2.10 | $210 | 20,641 |
| 2022-08-16 | WENTWORTH KORY JAMES Chief Financial Officer | Sale | −200 | $13.00 | $3K | 20,441 |
| 2022-08-16 | WENTWORTH KORY JAMES Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −100 | 116,096 | ||
| 2022-07-27 | Doshi Dipal President and CEO | Sale | −2,000 | $12.00 | $24K | 208,710 |
| 2022-07-01 | WENTWORTH KORY JAMES Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +33,019 | 33,019 | ||
| 2022-07-01 | KREHER NERISSA Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +31,032 | 31,032 | ||
| 2022-07-01 | Dowden Nathan J Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +33,788 | 33,788 | ||
| 2022-07-01 | Sethuraman Natarajan Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +34,763 | 34,763 | ||
| 2022-07-01 | Doshi Dipal President and CEO | Grant or award · Stock Option (Right to Buy) | +90,750 | 90,750 | ||
| 2022-06-27 | Dowden Nathan J Chief Operating Officer | Sale | −7,714 | $13.00 | $100K | 64,893 |
| 2022-06-27 | Doshi Dipal President and CEO | Sale | −4,000 | $12.00 | $48K | 210,710 |
| 2022-06-06 | BAKER BROS. ADVISORS LP 10% owner | Purchase | +921 | $6.35 | $6K | 361,043 |
| 2022-06-06 | BAKER BROS. ADVISORS LP 10% owner | Purchase | +7,815 | $6.35 | $50K | 4,475,208 |
| 2022-06-06 | BAKER BROS. ADVISORS LP 10% owner | Purchase | +3,118 | $6.42 | $20K | 364,161 |
Page 24 of 26 · 517 trades